FDA Approved: CLOPIDOGREL — Supplemental Application (NorthStar RxLLC)

View source ↗

Summary

FDA approved a supplemental application for clopidogrel filed by NorthStar RxLLC under an ANDA. The action indicates regulatory clearance for changes to the app…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Myocardial Infarction
• Peripheral Artery Disease
• Stroke

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

SUPPL AP for CLOPIDOGREL (CLOPIDOGREL)